Taylor Schreiber
Net worth: 16 M $ as of 31/05/2026
Net worth: 16 M $ as of 31/05/2026
Taylor H.
Schreiber is the founder of Shattuck Labs, Inc., established in 2016, serving as Chief Executive Officer & Director since 2020.
Former jobs include Director at Pelican Therapeutics, Inc. from 2011 to 2017 and Chief Scientific Officer at Scorpius Holdings, Inc. from 2015 to 2016.
Education includes undergraduate studies at Bucknell University and a doctorate from The University of Miami Leonard M.
Miller School of Medicine.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SHATTUCK LABS, INC. 3.56% | 12/05/2026 | 2,732,972 ( 3.56% ) | 16 M $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| SHATTUCK LABS, INC. | Founder | 01/01/2016 |
| Companies | Position | End |
|---|---|---|
Pelican Therapeutics, Inc.
Pelican Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic biological agents for immuno-oncology combinations | Director/Board Member | 01/01/2017 |
| SCORPIUS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 31/12/2016 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Scorpius Holdings, Inc.
Scorpius Holdings, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of therapies | Health Technology |
Pelican Therapeutics, Inc.
Pelican Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic biological agents for immuno-oncology combinations | Health Technology |
Bucknell University
Bucknell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Miami Leonard M. Miller School of Medicine
The University of Miami Leonard M. Miller School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shattuck Labs, Inc.
Shattuck Labs, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics for inflammatory and immune-mediated diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions